Therefore, based on the findings of the current study, it is suggested that RAAS inhibitors modifying the level of PTGS2 expression in various tissues of DN kidneys may be associated with acute kidney damage, although the precise mechanism of action remains unclear. The gene discussed is PTGS2; the disease is liver dysplastic nodule.